EMV Capital acquires leading Silicon Valley telehealth firm Wanda
17th April 2019
Level39 member EMV Capital has today announced the acquisition and investment into Wanda, a San Francisco-based digital health company commercialising advanced clinical decision support software.
EMV’s investment into the business will power Wanda’s growth in the US market, and enable the firm to enter into UK and European markets.
“I’m excited to welcome Wanda, an innovative digital health company into the EMV Capital family” said Dr. Ilian Iliev managing director of EMV Capital. “Wanda has shown impact and strong traction in the past couple of years and we are excited to support the company’s team through its growth phase. It fits in our investment thesis of backing exciting AI-powered technology platforms that can scale rapidly through industry partnerships.”
“We are delighted to welcome EMV Capital’s smart venture strategy. Their expertise in B2B technology investments and network of corporate partners will support Wanda’s growth stage,” commented Foad Dabiri, Co-Founder and CEO of Wanda. “We are very excited that Wanda has reached a stage where its products and technology have proven their value to our partners and clients and now it is time for the next exciting chapter in its mission.”
Wanda combines machine learning, virtual care and modern software to empower healthcare providers to better manage the risk and outcomes of caring for patients with chronic diseases such as heart failure. This dramatically lowers the cost of care while improving patients adherence and outcomes. The software was founded from the results of clinical trials at UCLA. Find out more about Wanda here.
L39 member EMV Capital an an early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart-cities, healthcare and transportation sectors. The firm was awarded the Best EIS Newcomer 2018 by the EIS Association in their yearly prize giving ceremony.